US Patent

US8722619 — Antifungal agents and uses thereof

Method of Use · Assigned to Seachaid Pharmaceuticals LLC · Expires 2032-03-02 · 6y remaining

Vulnerability score 76/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects the use of echinocandin class compounds for the treatment of fungal infections.

USPTO Abstract

The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections.

Drugs covered by this patent

rezafungin-acetate (REZAFUNGIN ACETATE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3566`	—	rezafungin-acetate

Patent Metadata

Patent number: US8722619
Jurisdiction: US
Classification: Method of Use
Expires: 2032-03-02
Drug substance claim: Yes
Drug product claim: Yes
Assignee: Seachaid Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.